Literature DB >> 12116849

Persistence of human parvovirus B19 in human tissues.

Maria Söderlund-Venermo1, Kati Hokynar, Janne Nieminen, Henna Rautakorpi, Klaus Hedman.   

Abstract

Human parvovirus B19 infection causes various clinical symptoms, such as rash, arthropathy, anemias and fetal death, but it can also remain asymptomatic. The arthropathies and anemias can become chronic for several years, not infrequently resembling autoimmune syndromes. B19 replicates only in red blood cell precursors of bone marrow or fetal liver, resulting in high-titred short-lived viremia, but viral DNA is detectable also in cells of several other types. Recently B19 DNA has been found, by very sensitive amplification tests, in certain tissues not only of symptomatic but also of healthy individuals for several years or decades after B19 infection. The mere presence of B19 DNA in these tissues of a symptomatic patient (e.g. joints in chronic arthritis or skin in dermatomyositis) thereby does not prove that the present disease is caused by B19. The diagnosis has to be verified by other innovative means. How and why viral DNA persists in the tissues of healthy individuals is under investigation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116849     DOI: 10.1016/s0369-8114(02)00307-3

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  35 in total

1.  Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.

Authors:  Anna Ekman; Kati Hokynar; Laura Kakkola; Kalle Kantola; Lea Hedman; Heidi Bondén; Matthias Gessner; Claudia Aberham; Päivi Norja; Simo Miettinen; Klaus Hedman; Maria Söderlund-Venermo
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

2.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

3.  Genomic features of the human bocaviruses.

Authors:  Oliver Schildgen; Jianming Qiu; Maria Söderlund-Venermo
Journal:  Future Virol       Date:  2012-01-01       Impact factor: 1.831

4.  Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans.

Authors:  Oscar Norbeck; Adiba Isa; Christoph Pöhlmann; Kristina Broliden; Victoria Kasprowicz; Paul Bowness; Paul Klenerman; Thomas Tolfvenstam
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue.

Authors:  Päivi Norja; Kati Hokynar; Leena-Maija Aaltonen; Renwei Chen; Annamari Ranki; Esa K Partio; Olli Kiviluoto; Irja Davidkin; Tomi Leivo; Anna Maria Eis-Hübinger; Beate Schneider; Hans-Peter Fischer; René Tolba; Olli Vapalahti; Antti Vaheri; Maria Söderlund-Venermo; Klaus Hedman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

6.  The relationship between arthritis and human parvovirus B19 infection.

Authors:  R Caliskan; S Masatlioglu; M Aslan; S Altun; S Saribas; S Ergin; E Uckan; V Koksal; V Oz; K Altas; I Fresko; B Kocazeybek
Journal:  Rheumatol Int       Date:  2004-08-20       Impact factor: 2.631

7.  Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture.

Authors:  Violetta Kivovich; Leona Gilbert; Matti Vuento; Stanley J Naides
Journal:  Int J Med Sci       Date:  2010-05-25       Impact factor: 3.738

8.  Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.

Authors:  Mattias Magnusson; Mikael Brisslert; Kiandoht Zendjanchi; Magnus Lindh; Maria I Bokarewa
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

9.  High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.

Authors:  Colin P Sharp; Alice Lail; Sharyne Donfield; Ruth Simmons; Clifford Leen; Paul Klenerman; Eric Delwart; Edward D Gomperts; Peter Simmonds
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

10.  Parenteral transmission of the novel human parvovirus PARV4.

Authors:  Peter Simmonds; Ashleigh Manning; Rachel Kenneil; Frances W Carnie; Jeanne E Bell
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.